An in vivo study of let-7 showed that its administration was effective against lung and breast cancers in mice and further computational analysis suggested that let-7 would be effective in estrogen receptor positive (ER+) metastatic breast cancer [6]. The gene discussed is ESR1; the disease is breast cancer.